Cetera Investment Advisers lowered its position in shares of Genpact Limited (NYSE:G – Free Report) by 21.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,498 shares of the business services provider’s stock after selling 11,028 shares during the quarter. Cetera Investment Advisers’ holdings in Genpact were worth $1,782,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in G. Wealth Enhancement Advisory Services LLC raised its stake in Genpact by 2.5% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 9,890 shares of the business services provider’s stock valued at $454,000 after purchasing an additional 240 shares during the last quarter. Sylvest Advisors LLC grew its holdings in shares of Genpact by 1.5% during the second quarter. Sylvest Advisors LLC now owns 17,902 shares of the business services provider’s stock worth $788,000 after buying an additional 258 shares in the last quarter. Louisiana State Employees Retirement System raised its position in shares of Genpact by 0.7% in the second quarter. Louisiana State Employees Retirement System now owns 45,300 shares of the business services provider’s stock valued at $1,994,000 after buying an additional 300 shares during the last quarter. Petrus Trust Company LTA lifted its stake in shares of Genpact by 2.2% in the first quarter. Petrus Trust Company LTA now owns 14,390 shares of the business services provider’s stock worth $725,000 after buying an additional 305 shares in the last quarter. Finally, Ballentine Partners LLC lifted its stake in shares of Genpact by 2.6% in the second quarter. Ballentine Partners LLC now owns 13,581 shares of the business services provider’s stock worth $598,000 after buying an additional 338 shares in the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.
Genpact Price Performance
G stock opened at $44.06 on Monday. Genpact Limited has a 52-week low of $37.49 and a 52-week high of $56.76. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 0.33. The stock has a market cap of $7.60 billion, a price-to-earnings ratio of 14.21, a price-to-earnings-growth ratio of 1.41 and a beta of 0.75. The business has a fifty day moving average of $41.45 and a two-hundred day moving average of $43.01.
Genpact Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, December 9th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.5%. The ex-dividend date is Tuesday, December 9th. Genpact’s dividend payout ratio is currently 21.94%.
Wall Street Analyst Weigh In
G has been the subject of a number of recent research reports. Wall Street Zen upgraded shares of Genpact from a “hold” rating to a “buy” rating in a report on Saturday, November 15th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Genpact in a report on Wednesday, October 8th. JPMorgan Chase & Co. reduced their price objective on Genpact from $55.00 to $50.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 20th. Citigroup upgraded Genpact to a “hold” rating in a report on Thursday, October 23rd. Finally, Needham & Company LLC raised their target price on Genpact from $50.00 to $53.00 and gave the stock a “buy” rating in a research note on Friday, August 8th. Three investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $51.13.
View Our Latest Research Report on Genpact
Insider Activity at Genpact
In other Genpact news, Director Tamara Franklin sold 2,750 shares of the company’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $45.65, for a total transaction of $125,537.50. Following the transaction, the director directly owned 22,236 shares in the company, valued at $1,015,073.40. This represents a 11.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Balkrishan Kalra sold 55,000 shares of the firm’s stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $43.36, for a total value of $2,384,800.00. Following the transaction, the chief executive officer owned 295,246 shares of the company’s stock, valued at approximately $12,801,866.56. This represents a 15.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 161,183 shares of company stock worth $6,970,760. Company insiders own 2.80% of the company’s stock.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles
- Five stocks we like better than Genpact
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Worried About Inflation? These 3 ETFs Offer Real Protection
- Upcoming IPO Stock Lockup Period, Explained
- Intel’s Black Friday Breakout: Apple Rumors Fuel a Holiday Rally
- What is a penny stock? A comprehensive guide
- Klarna’s Crypto Play: A Plan to Fix Its Profit Problem
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
